About 1−5% of BCs were attributed to BRCA1/BRCA2 mutations in primarily Caucasian BC populations23 while 3−7% of BCs were attributed to BRCA1/BRCA2 mutations in Asian BC24. This evidence concerns the gene BRCA1 and breast cancer.